Now that Q2 reporting is almost done I thought it would be a good idea to do a check on my portfolio and its status. Please note, I am not bragging. As I noted previously, putting my thinking in front of people pushes me to think harder and do a better job at due diligence. So I perform better.
Below is my portfolio performance as of today. You can see live portfolio and other stocks I analyzed here: https://www.wininstocks.com/watch-list-and-portfolio
Mogo Inc. (MOGO) update
Alerted MOGO Inc. back in January. Since then stock declined from $2.6 to under $1. During the decline, I doubled down on it twice as I think the stock is a rockstar. And it did not fail me.
Premarket on July 15th MOGO announced that it will report the following data on the date of the official earnings release (Aug 11th). That day the price spiked all the way to $3.20 but declined mid-day. For the past few days, it climbed back up to $2.30.
The company announced the preliminary Second Quarter 2020 Financial Results premarket on July 15th. Mogo is expecting to report:
· Revenue of $10.3 million to $10.5 million;
· Adjusted EBITDA of $4.5 million to $5.0 million; and
· Positive operating cash flow net of investing activities of $6.5 million to $7.0 million
I am holding it with the first target of $4, then $8.
Square Inc. (SQ) update
Alerted Square Inc. back in January. Since then doubled down on the bottom of the COVID drop. Currently holding with a good profit.
Based on my analysis here: https://www.wininstocks.com/post/does-square-inc-sq-still-have-the-steam-to-keep-going the stock is getting into the overpriced area (to my mind). But I am just watching it to see if the stock price chart shows a sell signal.
Beyond Meat Inc. (BYND) update
Beyond Meat Inc. (BYND) is a bit shaky with a mix of positive and negative news over the past few months. In the most recent Earnings release (Aug 4th) the company reported a wider loss than was expected. However, the management provided a note that the increased loss is due to a one-time expense to move their products from food service to retail. At the same time, the company grew sales 68.47% YOY and beat this quarter's estimates on revenue by 13.48%.
I do believe this is a positive sign and the company can get to profitability very quickly.
Canada Goose Inc. (GOOS) update
Canada Goose Inc. has not yet shared Q2 results (due Aug 12th). I first bought the stock pre-COVID and still believe in the company, so I double-downed on it during COVID.
The key for the company is the sales growth in Asia and China in particular. Will be watching that when they release the results.
Solaredge Technologies (SEDG) update
All I can say is 'Thank you, SEDG'. Been a good run so far and the earnings beat on Aug 3th was spectacular. I strongly believe the company will keep going and has room to grow more in the next 23-4 years. Here is my analysis: https://www.wininstocks.com/post/does-solaredge-sedg-have-the-steam-to-keep-going-could-jks-present-a-better-opportunity
Marathon Petroleum Corp (MPC) update
This was a play on COVID stock market meltdown and oil going to its minimum levels. I did not do any analysis, just bought it. So far the stock is up 100% but has been underperforming recently despite an earnings beat on Aug 3rd (delivered $0.01 vs. -$1.73 expected). What's worse it is not moving while oil broke through the resistance level. Should have stuck with CNQ instead.
Holding to see if it starts moving again. Otherwise, put a stop at $32.
Comerica Incorporated (CMA) update
Another COVID bottom play. Bought it based on the drop in price, strong dividend yield. The company released earnings report on July 21st where it beat earnings expectations. However, the stock showed little movement since then. Holding to see what happens next. If anything, I will take the 7% per annum dividend.
BOSTON OMAHA Corp (BOMN) update
The company has been growing revenue over the past few years, but its profit is hovering around 0 line. Waiting to see if it can churn a stable profit. It just released earnings report today where it showed $0.14 EPS, but this positive news was coupled with a drop in revenue.
Going to hold it for the next 3 months. If it does not move will sell.
JinkoSolar Holding Co. (JKS)
I performed an analysis here: https://www.wininstocks.com/post/does-solaredge-sedg-have-the-steam-to-keep-going-could-jks-present-a-better-opportunity
Over the past few months, the company released quite a few good news and the price was moving. The company will be releasing its Q2 Earnings Report on Aug 20th at which point we will see if the 'good new' convert into something tangible.
New Age Beverages Corp (NBEV)
I did a recent analysis on NBEV as part of Top 15 Stock about to hit Profitability analysis here: https://www.wininstocks.com/post/top-15-stocks-of-companies-with-fastest-growing-sales-in-2020-that-are-about-to-hit-profitability
The company is going to be reporting its financial results on August 10th.
Amarin Corp (AMRN)
Amarin Corp (AMRN) released earnings on Aug 4th at which point it beat estimates ($0.01 reported vs. -$0.07 estimate). It also grew sales. However, the stock price did not move much as investors are not sure these improvements are sustainable.
Holding till next quarter's report.
Enova International Inc (ENVA)
Nice volume and increase on the day of Earnings release (72% beat). Since then was going up. Need to see if it can break through that resistance line, which I believe will eventually do.
BioDelivery Sciences (BDSI)
Results on Aug 5th were not that exciting on the first look ($0.01 vs. $0.03 predicted). However, the company grew sales by 21% vs. the previous quarter. Also, this is a solid profitable quarter (one of the very few) that seems to be the new norm now. I believe profit will quickly go up.
Holding until next quarter results.
Antares Pharma Inc (ATRS)
Nice breakout from the triangle and then bounce off the resistance on Earnings beat news.
Pfenex Inc (PFNX)
Pfenex Inc. released Q2 results and business update yesterday after market close:
The revenues declined as was expected. However, there is an important business update:
Pfenex enters into a new research collaboration and license agreement with Merck & Co. Inc., with the potential to earn up to $293M in upfront, development, and sales milestones.
The new deal with Merck worth more than current market cap. 455million in outstanding royalties payable and 60m in cash with a market cap of 250m.
The stock is up this morning.
Intelligent Systems Corp (INS)
Nice breakout from the channel on Earnings beat news.